Quick Answer
Wave Life Sciences Ltd. reported Earnings Per Share Diluted of $1.21 (loss) per share for the year ending 2025.
- Wave Life Sciences Ltd. showed a decrease of -72.9% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Wave Life Sciences Ltd.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $0.78 (loss) per share | Q3 2021: $0.12 (loss) per share | Q1 2022: $0.62 (loss) per share | Q2 2022: $0.62 (loss) per share | Q3 2022: $0.42 (loss) per share | Q1 2023: $0.27 (loss) per share | Q2 2023: $0.20 (loss) per share | Q3 2023: $0.07 per share | Q1 2024: $0.24 (loss) per share | Q2 2024: $0.25 (loss) per share | Q3 2024: $0.47 (loss) per share | Q1 2025: $0.29 (loss) per share | Q2 2025: $0.31 (loss) per share | Q3 2025: $0.32 (loss) per share.
- Over the full 5 years of available data (2021 to 2025), Wave Life Sciences Ltd.'s Earnings Per Share Diluted has grown by 48.7%.
- Historical annual values: Fiscal year 2025: $1.21 (loss) per share | Fiscal year 2024: $0.70 (loss) per share | Fiscal year 2023: $0.54 (loss) per share | Fiscal year 2022: $2.05 (loss) per share | Fiscal year 2021: $2.36 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: